Hindustan Bio Sciences Ltd

The next results date for Hindustan Bio Sciences Ltd is January 31, 2026.

On 28-Nov, Hindustan Bio Sciences Ltd witnessed a notable decline in its share price, closing at ₹6.10, down by ₹0.20 or 3.17% as of 08:35 PM. This drop marks a fresh 52-week low for the stock, reflecting ongoing challenges despite increased investor activity.

As of 18-Nov, Hindustan Bio Sciences Ltd's stock price is Rs 6.59, down -4.91%, and has fallen -9.6% over the last two days. The stock is trading below all key moving averages and is close to its 52-week low, with significantly decreased investor participation.

As of November 3, 2025, Hind.Bio Science is considered overvalued with a PE ratio of 54.70, significantly higher than its peers, and has underperformed the Sensex year-to-date, indicating a risky investment.

Hind.Bio Science has experienced fluctuating financial performance, with net sales declining from 3.56 Cr in Mar'19 to 0.81 Cr in Mar'25, though profitability metrics show signs of recovery, particularly with an operating profit margin improving to 12.35% in Mar'25. Total liabilities and assets have also decreased during this period, while cash flow from operations has remained stagnant.

As of 30-Oct, Hindustan Bio Sciences Ltd's stock price is at 7.14, up 5.0% recently, but it has declined 15.00% over the past month and 30.07% year-to-date. Despite a short-term gain, the stock's delivery volume has dropped significantly, indicating reduced investor interest.

As of 24-Oct, Hindustan Bio Sciences Ltd's stock price is Rs. 6.57, down 9.88% and at a new 52-week low, having declined 26.92% over the past three days. The stock has underperformed its sector and major benchmarks, despite a notable increase in delivery volume, indicating limited investor interest amidst a broader market recovery.

As of 23-Oct, Hindustan Bio Sciences Ltd's stock price is at 7.29, down 10.0%, and has underperformed significantly with an 18.91% total return drop over two days. It is trading below all moving averages, indicating a bearish trend, and has seen a 65.19% decrease in delivery volume, reflecting reduced investor participation.

As of 20-Oct, Hindustan Bio Sciences Ltd's stock price has risen to 8.99, reflecting an increase of 8.97%. The stock has shown strong short-term performance, outperforming the Sensex, but has underperformed year-to-date.

Hind.Bio Science will announce its results on 31 October 2025.

As of 15-Oct, Hindustan Bio Sciences Ltd's stock price is at 8.49, having increased by 8.85% today after five days of decline, with significant investor participation indicated by an 83.17% rise in delivery volume. Despite a year-to-date decline of 16.85%, the stock has shown strong long-term performance with an 87.83% return over three years.

As of 13-Oct, Hindustan Bio Sciences Ltd's stock price is declining at 7.97, down 3.39%, and has underperformed its sector. The stock is trading below all major moving averages, with a significant drop in investor participation and a year-to-date decline of 21.94%.

As of 24-Sep, Hindustan Bio Sciences Ltd is seeing a price increase to 8.47, with a 5.74% return over the last four days and a significant rise in delivery volume. Despite a year-to-date decline of 17.04%, the stock has outperformed the Sensex and shows strong long-term growth potential.

As of 23-Sep, Hindustan Bio Sciences Ltd's stock price is at 8.43, up 4.98% over three days, but down 17.43% year-to-date. Despite recent gains, a significant drop in delivery volume raises concerns about future price stability.

As of 22-Sep, Hindustan Bio Sciences Ltd is priced at 8.03, with a slight increase of 0.12%. Despite recent gains, the stock is trading below its moving averages and has seen a significant drop in investor participation, indicating potential weakness and reduced interest.